Austin, TX, USA, July 25, 2025 (GLOBE NEWSWIRE) — Custom Market Insights has published a new research report titled “CRISPR Gene Editing Market Size, Trends and Insights By Product (Kits and Reagents, Services), By Gene Editing Modality (Ex-Vivo Editing, In-Vivo Editing), By Technology (CRISPR/Cas9 Technology, CRISPR/Cas12 Technology, Prime Editing, Epigenetic Editing, Others), By Application (Therapeutic Applications, Agriculture and Livestock, Industrial Biotechnology), By End User (Biotechnology and Pharmaceutical Companies, Agricultural and Livestock Industry, Hospitals and Clinics, Others), and By Region – Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034“ in its research database.
“According to the latest research study, the demand of the global CRISPR Gene Editing Market size & share was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach a value of around USD 12.6 Billion by 2034, at a compound annual growth rate (CAGR) of about 13.01% during the forecast period 2025 to 2034.”
Click Here to Access a Free Sample Report of the Global CRISPR Gene Editing Market @ https://www.custommarketinsights.com/request-for-free-sample/?reportid=71390
Overview
As per the industry experts at CMI, Major players in the CRISPR gene editing segment such as CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., and GeneCopoeia Inc., are enhancing precision gene editing via scalable platforms and solutions from synthetic biology. With the automation and genomic cloud computing these companies intend to enhance CRISPR’s precision and efficacy, they will utilize AI-generated guide RNAs.
Other active ventures focus on plant and agricultural biopharmaceuticals, therapeutic biopharmaceuticals, or functional genomics. Collaborations between universities, clinics, and the biotech sector are on the rise, which accelerates innovation and globalization. Compliance with FDA, EMA, ISO, ESG, and CSR requirements strengthens green laboratory sustainability initiatives. These enduring strategic focuses enable still transformative advances in CRISPR.
Key Trends & Drivers
The Rise in Demand for Personalized Medicine: This is the increasing need for treatments based on and tailored to an individual’s genetic composition. This increases efficiency and reduces adverse drug reactions. CRISPR technology aids in this by enabling on-target, specific edits. In March 2025, a CRISPR-based therapy received expanded orphan drug designation from the FDA for treating a rare genetic liver metabolic disorder which marked a regulatory milestone. Furthermore, pharmaceutical manufacturers have several personalized CRISPR clinical programs in progress for sickle cell and retinal diseases. These initiatives highlight the increasing momentum and investment behind tailored patient-specific, gene-editing therapies. As trials expand, the clinical availability of tailored CRISPR therapies approaches reality.
Growth in Agricultural Biotechnology: This concerns the application of CRISPR technology for modification of essential traits in crops like yield, climate resilience and pest resistance to solve food crises around the world. There is relaxed concern with GMO crops as emerging markets are granting less red tape than traditional GMOs to genome edited crops. In late 2024, a multinational agri-biotech consortium conducted successful pilot trials of drought resistant CRISPR maize in sub-saharan Africa. Since then, major seed companies have formed alliances aimed at bringing these next generation crops to market. The surge in the funding of agricultural startups specializing in gene editing technologies reached nearly double the amount received throughout 2024 in the first quarter of 2025. This strongly substantiates the impact and promise of CRISPR on sustainable agriculture.
Request a Customized Copy of the CRISPR Gene Editing Market Report @ https://www.custommarketinsights.com/request-for-customization/?reportid=71390
The Integration of Synthetic Biology: The rise of synthetic biology is a relatively more recent phenomenon within the life sciences. Synthetic biology is the infusion of CRISPR genetic modification into frameworks designated for creating biomaterials, therapeutics, and diagnostics. It promotes creativity by programming biological functions into living organisms. In January 2025, one of the leaders in the industry launched a fully automated CRISPR workstation that designs host organisms for enzyme production. In the same quarter, CRISPR editing kits meant for easier construction of sophisticated metabolic pathways were issued. These tools which permit rapid prototyping and bioproduction, are alleviating constraints in biomanufacturing. The remarkable progress made in synthetic biology is motivating the greater adoption of CRISPR technologies by the industrial and academic sectors.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 4.10 Billion |
| Projected Market Size in 2034 | USD 12.6 Billion |
| Market Size in 2024 | USD 3.65 Billion |
| CAGR Growth Rate | 13.01% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Product, Gene Editing Modality, Technology, Application, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
(A free sample of the CRISPR Gene Editing report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package.
- About 220+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on the Request.
- Updated Regional Analysis with a Graphical Representation of Size, Share, and …